TokenPost·
Protagenic Therapeutics Announces Placement With Up to $5 Million in Potential Proceeds
The company plans to use proceeds for PT00114 development, working capital and general corporate purposes.
More news
- TokenPostDecrypt Plans Phoenix Perps Integration for Solana Money Accounts
- TokenPostEdelbyte Raises $70 Million Across Seed and Series A Rounds
- TokenPostBroadcom Shares Rise 3.91% as Anthropic Filing Lists Planned $1 Billion Purchase
- CryptoSlateFSB pressures Turkey regulators to lock down foreign stablecoins
- TokenPostAdobe Previews 10 Research Projects at Its MAX Sneaks Session
- TokenPostPlurai Raises $13 Million to Simulate Enterprise AI Agent Tasks